A novel nanoparticle blood test detects an overall increase of human immunoglobulin G (IgG), including the tumor-specific autoantibodies, adsorbed to a gold nanoparticle surface. While this test may not be able to identify the specific type of cancer, it may potentially be able to detect early stage tumor-induced immune responses associated with a broad spectrum of cancer types, making this test potentially a universal screening test for cancer risk assessment.
Typically, in clinical formulations of Magnetic Resonance Imaging (MRI) contrast agents, gram quantities of Gd(III) are needed to achieve sufficiently high contrast for examination. That's why the research imaging community is interested in developing new formulations of contrast agents able to bridge the gap between high contrast imaging of contrast agents dosed at low concentrations.
In new work, researchers report a new class of gold nanoconjugates that exhibit exceptionally high relaxivities at both low and high field strengths.
Trying to develop chemical free disinfection techniques, researchers are currently exploring the effectiveness of a nanotechnology based intervention method for the inactivation of foodborne and spoilage microorganisms on fresh produce and on food production surfaces. This method utilizes Engineered Water Nanostructures (EWNS) generated by electrospraying of water. These EWNS are 25 nm in diameter; remain airborne in indoor conditions for hours; contain Reactive Oxygen Species (ROS); have very strong surface charge (on average 10 electrons per structure) and have the ability to interact and inactivate pathogens by destroying their membrane.
Researchers have developed a magnetic bead based sensor that combines magnetic separation (MS) and magnetic relaxation switch (MRS) for one-step detection of bacteria and viruses with high sensitivity and reproducibility. Compared to conventional assays for detection of bacteria and viruses, this novel MS-MRS assay is easy to operate without laborious pre-treatment, purification and can be adaptable to point-of-care tests easily.
Historically, the approval of Doxil as the very first nanotherapeutic product in 1995 is generally regarded as the dawn of nanomedicine for human use. Although numerous products classified as nanomedicine products have indeed appeared over the past decade, such products have not exactly revolutionized treatment paradigms as envisaged earlier. In particular no molecular machine or nanorobot has yet entered clinical trials, although research in these areas is picking up pace.
An international team of researchers used abiotic assays, cultured cancer cells, and a melanoma animal model to demonstrate the photothermal therapy (PTT) activity of copper sulfide nanocrystals. The research lays out the working principle of colloidal, near-infrared light (NIR) plasmonic copper sulfide nanocrystals exploitable for both photodynamic therapy (PDT) and PTT therapy with NIR activation. This is the first report that under a NIR light radiation copper sulfide nanocrystals achieve efficient cancer destroying efficacy via PTT and PDT mechanisms both in vitro and in vivo.
So far, there have been very few research reports on single electrode materials that enable the simultaneous detection of different metabolites - such as glucose, urea, cholesterol, and triglycerides - in whole blood. Moreover, it is a considerable challenge to integrate all required materials and devices on a single chip to ultimately produce a multiplexing biosensor array. In new work, researchers demonstrate that biosensors based on conducting polymer hydrogels enable the precise and full-range detection of different metabolites in human blood.
Researchers have developed a simple method to thermally ablate highly resistant cancer cells using targeted biodegradable graphene nanoparticles. They found that graphene can convert non-ionizing radio waves - the same that are used in FM radios - into heat energy at microscopic levels. This heat is sufficient to completely destroy proteins and DNA inside individual cancer cells, irrespective of any kinds of resistant mechanisms that drives cancer cells at advanced stages.